• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CYC31,一种天然的溴酚类 PTP1B 抑制剂,可激活胰岛素信号通路并改善 C2C12 肌管中的长链脂肪酸氧化。

CYC31, A Natural Bromophenol PTP1B Inhibitor, Activates Insulin Signaling and Improves Long Chain-Fatty Acid Oxidation in C2C12 Myotubes.

机构信息

School of Public Health, Qingdao University, Qingdao 266071, China.

Key Laboratory of Experimental Marine Biology, Institute of Oceanology, Chinese Academy of Sciences, 7 Nanhai Road, Qingdao 266071, China.

出版信息

Mar Drugs. 2020 May 19;18(5):267. doi: 10.3390/md18050267.

DOI:10.3390/md18050267
PMID:32438641
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7281472/
Abstract

3-bromo-4,5-Bis(2,3-dibromo-4,5-dihydroxybenzyl)-1,2-benzenediol (CYC31) is a bromophenol protein tyrosine phosphatase 1B (PTP1B) inhibitor isolated from the red alga . Here, the effect of CYC31 on the insulin signaling and fatty-acid-induced disorders in C2C12 myotubes was investigated. Molecular docking assay showed that CYC31 was embedded into the catalytic pocket of PTP1B. A cellular study found that CYC31 increased the activity of insulin signaling and promoted 2-NBDG uptake through GLUT4 translocation in C2C12 myotubes. Further studies showed that CYC31 ameliorated palmitate-induced insulin resistance in C2C12 myotubes. Moreover, CYC31 treatment significantly increased the mRNA expression of carnitine palmitoyltransferase 1B () and fatty acid binding protein 3 (), which was tightly linked with fatty acid oxidation. These findings suggested that CYC31 could prevent palmitate-induce insulin resistance and could improve fatty acid oxidation through PTP1B inhibition.

摘要

3-溴-4,5-双(2,3-二溴-4,5-二羟基苯甲基)-1,2-苯二酚(CYC31)是从红藻中分离出的一种溴酚蛋白酪氨酸磷酸酶 1B(PTP1B)抑制剂。本文研究了 CYC31 对 C2C12 肌管胰岛素信号和脂肪酸诱导紊乱的影响。分子对接试验表明,CYC31 嵌入 PTP1B 的催化口袋中。细胞研究发现,CYC31 通过 GLUT4 易位增加 C2C12 肌管中的胰岛素信号活性并促进 2-NBDG 摄取。进一步的研究表明,CYC31 改善了 C2C12 肌管中棕榈酸诱导的胰岛素抵抗。此外,CYC31 处理显著增加了肉毒碱棕榈酰转移酶 1B()和脂肪酸结合蛋白 3()的 mRNA 表达,这与脂肪酸氧化密切相关。这些发现表明,CYC31 可通过抑制 PTP1B 预防棕榈酸诱导的胰岛素抵抗,并可改善脂肪酸氧化。

相似文献

1
CYC31, A Natural Bromophenol PTP1B Inhibitor, Activates Insulin Signaling and Improves Long Chain-Fatty Acid Oxidation in C2C12 Myotubes.CYC31,一种天然的溴酚类 PTP1B 抑制剂,可激活胰岛素信号通路并改善 C2C12 肌管中的长链脂肪酸氧化。
Mar Drugs. 2020 May 19;18(5):267. doi: 10.3390/md18050267.
2
BPN, a marine-derived PTP1B inhibitor, activates insulin signaling and improves insulin resistance in C2C12 myotubes.BPN,一种海洋来源的 PTP1B 抑制剂,可激活胰岛素信号通路并改善 C2C12 肌管中的胰岛素抵抗。
Int J Biol Macromol. 2018 Jan;106:379-386. doi: 10.1016/j.ijbiomac.2017.08.042. Epub 2017 Aug 12.
3
Design, synthesis, and biological evaluation of bromophenol derivatives as protein tyrosine phosphatase 1B inhibitors.设计、合成及溴酚类衍生物的生物评价作为蛋白酪氨酸磷酸酶 1B 抑制剂。
Arch Pharm (Weinheim). 2012 Jun;345(6):444-53. doi: 10.1002/ardp.201100373. Epub 2012 Feb 3.
4
Pyrroloquinoline quinone, a novel protein tyrosine phosphatase 1B inhibitor, activates insulin signaling in C2C12 myotubes and improves impaired glucose tolerance in diabetic KK-A(y) mice.吡咯并喹啉醌,一种新型的蛋白酪氨酸磷酸酶 1B 抑制剂,可激活 C2C12 肌管中的胰岛素信号通路,并改善糖尿病 KK-A(y) 小鼠的葡萄糖耐量受损。
Biochem Biophys Res Commun. 2012 Nov 16;428(2):315-20. doi: 10.1016/j.bbrc.2012.10.055. Epub 2012 Oct 22.
5
Protein tyrosine phosphatase 1B inhibition ameliorates palmitate-induced mitochondrial dysfunction and apoptosis in skeletal muscle cells.蛋白酪氨酸磷酸酶1B抑制可改善棕榈酸酯诱导的骨骼肌细胞线粒体功能障碍和细胞凋亡。
Free Radic Biol Med. 2013 Dec;65:1435-1446. doi: 10.1016/j.freeradbiomed.2013.09.019. Epub 2013 Oct 10.
6
Antidiabetic activity in vitro and in vivo of BDB, a selective inhibitor of protein tyrosine phosphatase 1B, from Rhodomela confervoides.来自孔叶红藻的蛋白酪氨酸磷酸酶1B选择性抑制剂BDB在体外和体内的抗糖尿病活性。
Br J Pharmacol. 2020 Oct;177(19):4464-4480. doi: 10.1111/bph.15195. Epub 2020 Aug 30.
7
Glucose Uptake Activities of Bis (2, 3-Dibromo-4, 5-Dihydroxybenzyl) Ether, a Novel Marine Natural Product from Red Alga Odonthaliacorymbifera with Protein Tyrosine Phosphatase 1B Inhibition, In Vitro and In Vivo.双(2,3-二溴-4,5-二羟基苄基)醚的葡萄糖摄取活性研究,一种来自红藻Odonthaliacorymbifera的新型海洋天然产物,具有体外和体内抑制蛋白酪氨酸磷酸酶1B的作用
PLoS One. 2016 Jan 25;11(1):e0147748. doi: 10.1371/journal.pone.0147748. eCollection 2016.
8
Astragalus polysaccharide improves palmitate-induced insulin resistance by inhibiting PTP1B and NF-κB in C2C12 myotubes.黄芪多糖通过抑制 C2C12 肌管中的 PTP1B 和 NF-κB 改善棕榈酸诱导的胰岛素抵抗。
Molecules. 2012 Jun 11;17(6):7083-92. doi: 10.3390/molecules17067083.
9
Selectivity, cell permeability and oral availability studies of novel bromophenol derivative HPN as protein tyrosine phosphatase 1B inhibitor.新型溴酚类衍生物 HPN 作为蛋白酪氨酸磷酸酶 1B 抑制剂的选择性、细胞通透性和口服生物利用度研究。
Br J Pharmacol. 2018 Jan;175(1):140-153. doi: 10.1111/bph.14080. Epub 2017 Dec 8.
10
Safranal, a novel protein tyrosine phosphatase 1B inhibitor, activates insulin signaling in C2C12 myotubes and improves glucose tolerance in diabetic KK-Ay mice.藏红花醛是一种新型蛋白酪氨酸磷酸酶1B抑制剂,可激活C2C12肌管中的胰岛素信号,并改善糖尿病KK-Ay小鼠的葡萄糖耐量。
Mol Nutr Food Res. 2014 Jun;58(6):1177-89. doi: 10.1002/mnfr.201300675. Epub 2014 Feb 12.

引用本文的文献

1
LZU-J-Q21 enhanced the functional metabolic profile and bioactivity of .兰州大学-J-Q21增强了……的功能代谢谱和生物活性。 (原文此处不完整,缺少具体所指内容)
Food Chem X. 2024 Oct 30;24:101941. doi: 10.1016/j.fochx.2024.101941. eCollection 2024 Dec 30.
2
Marine Polyphenols in Cardiovascular Health: Unraveling Structure-Activity Relationships, Mechanisms, and Therapeutic Implications.海洋多酚与心血管健康:解析结构-活性关系、作用机制及治疗意义。
Int J Mol Sci. 2024 Aug 1;25(15):8419. doi: 10.3390/ijms25158419.
3
Naturally Occurring Organohalogen Compounds-A Comprehensive Review.

本文引用的文献

1
Highly Selective Protein Tyrosine Phosphatase Inhibitor, 2,2',3,3'-Tetrabromo-4,4',5,5'-tetrahydroxydiphenylmethane, Ameliorates Type 2 Diabetes Mellitus in BKS db Mice.高选择性蛋白酪氨酸磷酸酶抑制剂,2,2',3,3'-四溴-4,4',5,5'-四羟基二苯甲烷,可改善 BKS db 小鼠 2 型糖尿病。
Mol Pharm. 2019 May 6;16(5):1839-1850. doi: 10.1021/acs.molpharmaceut.8b01106. Epub 2019 Apr 18.
2
Global aetiology and epidemiology of type 2 diabetes mellitus and its complications.2 型糖尿病及其并发症的全球病因学和流行病学。
Nat Rev Endocrinol. 2018 Feb;14(2):88-98. doi: 10.1038/nrendo.2017.151. Epub 2017 Dec 8.
3
Selectivity, cell permeability and oral availability studies of novel bromophenol derivative HPN as protein tyrosine phosphatase 1B inhibitor.
天然有机卤代化合物综述。
Prog Chem Org Nat Prod. 2023;121:1-546. doi: 10.1007/978-3-031-26629-4_1.
4
Therapeutic Potential of Polyphenols and Other Micronutrients of Marine Origin.海洋来源多酚类化合物和其他微量营养素的治疗潜力。
Mar Drugs. 2023 May 26;21(6):323. doi: 10.3390/md21060323.
5
The association between dietary inflammation index and depression.饮食炎症指数与抑郁症之间的关联。
Front Psychiatry. 2023 Mar 23;14:1131802. doi: 10.3389/fpsyt.2023.1131802. eCollection 2023.
6
Drug Discovery of Plausible Lead Natural Compounds That Target the Insulin Signaling Pathway: Bioinformatics Approaches.靶向胰岛素信号通路的潜在先导天然化合物的药物发现:生物信息学方法
Evid Based Complement Alternat Med. 2022 Mar 20;2022:2832889. doi: 10.1155/2022/2832889. eCollection 2022.
7
Targeting Breast Cancer and Their Stem Cell Population through AMPK Activation: Novel Insights.通过激活 AMPK 靶向乳腺癌及其干细胞群体:新的见解。
Cells. 2022 Feb 7;11(3):576. doi: 10.3390/cells11030576.
8
Activation of IGF-1 pathway and suppression of atrophy related genes are involved in Epimedium extract (icariin) promoted C2C12 myotube hypertrophy.淫羊藿提取物(淫羊藿苷)促进 C2C12 肌管肥大涉及 IGF-1 通路的激活和萎缩相关基因的抑制。
Sci Rep. 2021 May 24;11(1):10790. doi: 10.1038/s41598-021-89039-0.
9
Bioactive Properties of Marine Phenolics.海洋酚类的生物活性特性。
Mar Drugs. 2020 Sep 30;18(10):501. doi: 10.3390/md18100501.
10
Progress of Bromophenols in Marine Algae from 2011 to 2020: Structure, Bioactivities, and Applications.2011 年至 2020 年海洋藻类中溴酚类化合物的研究进展:结构、生物活性及应用。
Mar Drugs. 2020 Aug 4;18(8):411. doi: 10.3390/md18080411.
新型溴酚类衍生物 HPN 作为蛋白酪氨酸磷酸酶 1B 抑制剂的选择性、细胞通透性和口服生物利用度研究。
Br J Pharmacol. 2018 Jan;175(1):140-153. doi: 10.1111/bph.14080. Epub 2017 Dec 8.
4
Insulin Resistance, Obesity and Lipotoxicity.胰岛素抵抗、肥胖与脂毒性
Adv Exp Med Biol. 2017;960:277-304. doi: 10.1007/978-3-319-48382-5_12.
5
Exploring the ocean for new drug developments: Marine pharmacology.探索海洋以开发新药:海洋药理学。
J Pharm Bioallied Sci. 2016 Apr-Jun;8(2):83-91. doi: 10.4103/0975-7406.171700.
6
A novel protein tyrosine phosphatase 1B inhibitor with therapeutic potential for insulin resistance.一种对胰岛素抵抗具有治疗潜力的新型蛋白酪氨酸磷酸酶1B抑制剂。
Br J Pharmacol. 2016 Jun;173(12):1939-49. doi: 10.1111/bph.13483. Epub 2016 May 4.
7
High-fat load: mechanism(s) of insulin resistance in skeletal muscle.高脂肪负荷:骨骼肌中胰岛素抵抗的机制
Int J Obes Suppl. 2012 Dec;2(Suppl 2):S31-S36. doi: 10.1038/ijosup.2012.20.
8
Norathyriol reverses obesity- and high-fat-diet-induced insulin resistance in mice through inhibition of PTP1B.去甲环阿尔廷醇通过抑制蛋白酪氨酸磷酸酶1B逆转肥胖和高脂饮食诱导的小鼠胰岛素抵抗。
Diabetologia. 2014 Oct;57(10):2145-54. doi: 10.1007/s00125-014-3315-8. Epub 2014 Jul 2.
9
Safranal, a novel protein tyrosine phosphatase 1B inhibitor, activates insulin signaling in C2C12 myotubes and improves glucose tolerance in diabetic KK-Ay mice.藏红花醛是一种新型蛋白酪氨酸磷酸酶1B抑制剂,可激活C2C12肌管中的胰岛素信号,并改善糖尿病KK-Ay小鼠的葡萄糖耐量。
Mol Nutr Food Res. 2014 Jun;58(6):1177-89. doi: 10.1002/mnfr.201300675. Epub 2014 Feb 12.
10
AMPK, insulin resistance, and the metabolic syndrome.AMPK、胰岛素抵抗和代谢综合征。
J Clin Invest. 2013 Jul;123(7):2764-72. doi: 10.1172/JCI67227. Epub 2013 Jul 1.